相关实验视频

Updated: May 22, 2025

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells

Published on: February 21, 2019

查和功能性特征纳米体的向转激素受体的功能性特征

Yuting Ding¹, Li Jia¹, Qifubo Geng²

¹Department of Biopharmaceutics, College of Food Science and Technology, Shanghai Ocean University, Shanghai, 201306, China.

Protein expression and purification

|March 15, 2025

概括

研究人员开发了一个高效的平台,可以快速识别向转激素受体 (TfR1) 的纳米体. 他们发现了NB 2D7,它显示了癌症和铁代谢障碍的治疗潜力.

科学领域:

生物化学生物化学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

转移素受体 (TfR1) 对细胞铁吸收至关重要,影响血液学和瘤进展.
针对TfR1的纳米体 (NBs) 由于其有利的特性,是有前途的治疗方法,但需要有效的发现方法.

研究的目的:

为选抗TfR1纳米体建立一个高效的平台.
识别具有高亲和力和对TfR1.1治疗潜力的新型纳米体.

主要方法:

表达和净化了人类TfR1.1的细胞外域.
从免疫的驼动物中生成纳米体库.
使用菌体显示和高通量方法选图书馆来识别TfR1结合纳米体.

主要成果:

通过纳米分离常数 (KD) 成功识别了NB 2D7纳米体.
在CCK8试验中证明,NB 2D7和FeCl3的联合治疗降低了LoVo细胞存活率.

结论:

开发了一个有效的平台,用于反-TfR1纳米体的发现.
强调了NB 2D7在癌症治疗和铁代谢障碍方面的治疗潜力.

关键词:

癌症治疗治疗癌症治疗纳米人体查的方法转移素受体 (TfR1) 是一种转移素受体.

更多相关视频

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane SSM-Based Electrophysiology

Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane SSM-Based Electrophysiology

Published on: May 3, 2021

相关概念视频